Natixis’s West Pharmaceutical WST Stock Holding History

Natixis’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.67M	Buy	12,186 +5,717	+88%	+$1.25M	0.01%	418
2025 Q1	$1.44M	Buy	6,469 +2,060	+47%	+$458K	0.01%	472
2024 Q4	$1.44M	Buy	+4,409	New	+$1.44M	0.01%	526
2024 Q3	–	Sell	-1,178	Closed	-$388K	–	1122
2024 Q2	$388K	Sell	1,178 -19,132	-94%	-$6.3M	﹤0.01%	628
2024 Q1	$8.04M	Buy	20,310 +17,368	+590%	+$6.87M	0.04%	255
2023 Q4	$1.04M	Buy	2,942 +1,881	+177%	+$662K	0.01%	503
2023 Q3	$398K	Sell	1,061 -3,585	-77%	-$1.35M	﹤0.01%	629
2023 Q2	$1.78M	Buy	+4,646	New	+$1.78M	0.01%	436
2023 Q1	–	Sell	-9,646	Closed	-$2.27M	–	1161
2022 Q4	$2.27M	Buy	9,646 +4,728	+96%	+$1.11M	0.01%	467
2022 Q3	$1.21M	Buy	4,918 +1,152	+31%	+$284K	0.01%	683
2022 Q2	$1.14M	Buy	3,766 +302	+9%	+$91.2K	﹤0.01%	751
2022 Q1	$1.42M	Sell	3,464 -12,514	-78%	-$5.14M	0.01%	815
2021 Q4	$7.49M	Buy	15,978 +12,771	+398%	+$5.99M	0.03%	464
2021 Q3	$1.36M	Buy	+3,207	New	+$1.36M	﹤0.01%	808
2021 Q2	–	Sell	-25,332	Closed	-$7.14M	–	1121
2021 Q1	$7.14M	Sell	25,332 -13,287	-34%	-$3.74M	0.02%	439
2020 Q4	$10.9M	Sell	38,619 -20,227	-34%	-$5.73M	0.04%	374
2020 Q3	$16.2M	Sell	58,846 -3,402	-5%	-$935K	0.12%	158
2020 Q2	$14.1M	Buy	62,248 +49,027	+371%	+$11.1M	0.11%	154
2020 Q1	$2.01M	Buy	+13,221	New	+$2.01M	0.02%	384
2019 Q4	–	Sell	-25,249	Closed	-$3.58M	–	981
2019 Q3	$3.58M	Sell	25,249 -35,703	-59%	-$5.06M	0.02%	404
2019 Q2	$7.63M	Buy	60,952 +34,341	+129%	+$4.3M	0.06%	258
2019 Q1	$2.86M	Buy	+26,611	New	+$2.86M	0.02%	455
2018 Q3	–	Sell	-2,551	Closed	-$253K	–	993
2018 Q2	$253K	Buy	+2,551	New	+$253K	﹤0.01%	788
2018 Q1	–	Sell	-2,607	Closed	-$257K	–	985
2017 Q4	$257K	Sell	2,607 -3,079	-54%	-$304K	﹤0.01%	721
2017 Q3	$547K	Buy	5,686 +33	+0.6%	+$3.18K	0.01%	656
2017 Q2	$534K	Buy	5,653 +1,272	+29%	+$120K	0.01%	507
2017 Q1	$358K	Buy	4,381 +1,803	+70%	+$147K	﹤0.01%	624
2016 Q4	$219K	Buy	+2,578	New	+$219K	﹤0.01%	775